FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034352114> ?p ?o ?g. }

• W2034352114 endingPage "423" @default.
• W2034352114 startingPage "415" @default.
• W2034352114 abstract "Background During liver ischemia, the decrease in mitochondrial energy causes cellular damage that is aggravated after reperfusion. This injury can trigger a systemic inflammatory syndrome, also producing remote organ damage. Several substances have been employed to decrease this inflammatory response during liver transplantation, liver resections, and hypovolemic shock. The aim of this study was to evaluate the effects of hypertonic saline solution and the best timing of administration to prevent organ injury during experimental liver ischemia/reperfusion. Methods Rats underwent 1 hr of warm liver ischemia followed by reperfusion. Eighty-four rats were allocated into 6 groups: sham group, control of ischemia group (C), pre-ischemia treated NaCl 0.9% (ISS) and NaCl 7.5% (HTS) groups, pre-reperfusion ISS, and HTS groups. Blood and tissue samples were collected 4 hr after reperfusion. Results HTS showed beneficial effects in prevention of liver ischemia/reperfusion injury. HTS groups developed increases in AST and ALT levels that were significantly less than ISS groups; however, the HTS pre-reperfusion group showed levels significantly less than the HTS pre-ischemia group. No differences in IL-6 and IL-10 levels were observed. A significant decrease in mitochondrial dysfunction as well as hepatic edema was observed in the HTS pre-reperfusion group. Pulmonary vascular permeability was significantly less in the pre-reperfusion HTS group compared to the ISS group. No differences in myeloperoxidase activity were observed. The liver histologic score was significantly less in the pre-reperfusion HTS group compared to the pre-ischemia HTS group. Conclusion HTS ameliorated local and systemic injuries in experimental liver ischemia/reperfusion. Infusion of HTS in the pre-reperfusion period may be an important adjunct to accomplish the best results. During liver ischemia, the decrease in mitochondrial energy causes cellular damage that is aggravated after reperfusion. This injury can trigger a systemic inflammatory syndrome, also producing remote organ damage. Several substances have been employed to decrease this inflammatory response during liver transplantation, liver resections, and hypovolemic shock. The aim of this study was to evaluate the effects of hypertonic saline solution and the best timing of administration to prevent organ injury during experimental liver ischemia/reperfusion. Rats underwent 1 hr of warm liver ischemia followed by reperfusion. Eighty-four rats were allocated into 6 groups: sham group, control of ischemia group (C), pre-ischemia treated NaCl 0.9% (ISS) and NaCl 7.5% (HTS) groups, pre-reperfusion ISS, and HTS groups. Blood and tissue samples were collected 4 hr after reperfusion. HTS showed beneficial effects in prevention of liver ischemia/reperfusion injury. HTS groups developed increases in AST and ALT levels that were significantly less than ISS groups; however, the HTS pre-reperfusion group showed levels significantly less than the HTS pre-ischemia group. No differences in IL-6 and IL-10 levels were observed. A significant decrease in mitochondrial dysfunction as well as hepatic edema was observed in the HTS pre-reperfusion group. Pulmonary vascular permeability was significantly less in the pre-reperfusion HTS group compared to the ISS group. No differences in myeloperoxidase activity were observed. The liver histologic score was significantly less in the pre-reperfusion HTS group compared to the pre-ischemia HTS group. HTS ameliorated local and systemic injuries in experimental liver ischemia/reperfusion. Infusion of HTS in the pre-reperfusion period may be an important adjunct to accomplish the best results." @default.
• W2034352114 created "2016-06-24" @default.
• W2034352114 creator A5006000018 @default.
• W2034352114 creator A5009157759 @default.
• W2034352114 creator A5018778070 @default.
• W2034352114 creator A5024426707 @default.
• W2034352114 creator A5027014989 @default.
• W2034352114 creator A5027538692 @default.
• W2034352114 creator A5040079063 @default.
• W2034352114 date "2010-03-01" @default.
• W2034352114 modified "2023-10-07" @default.
• W2034352114 title "Timing-dependent protection of hypertonic saline solution administration in experimental liver ischemia/reperfusion injury" @default.
• W2034352114 cites W1775749144 @default.
• W2034352114 cites W1916974964 @default.
• W2034352114 cites W1965514449 @default.
• W2034352114 cites W1968988918 @default.
• W2034352114 cites W1970106233 @default.
• W2034352114 cites W1975856094 @default.
• W2034352114 cites W1979447888 @default.
• W2034352114 cites W1985902544 @default.
• W2034352114 cites W1991336302 @default.
• W2034352114 cites W2005464938 @default.
• W2034352114 cites W2005733377 @default.
• W2034352114 cites W2007586058 @default.
• W2034352114 cites W2007947120 @default.
• W2034352114 cites W2012826017 @default.
• W2034352114 cites W2019595756 @default.
• W2034352114 cites W2028219685 @default.
• W2034352114 cites W2037745415 @default.
• W2034352114 cites W2039370735 @default.
• W2034352114 cites W2042851915 @default.
• W2034352114 cites W2043776850 @default.
• W2034352114 cites W2044410575 @default.
• W2034352114 cites W2051893845 @default.
• W2034352114 cites W2052412773 @default.
• W2034352114 cites W2061925047 @default.
• W2034352114 cites W2068144001 @default.
• W2034352114 cites W2077022750 @default.
• W2034352114 cites W2077620284 @default.
• W2034352114 cites W2082020065 @default.
• W2034352114 cites W2085685269 @default.
• W2034352114 cites W2086783188 @default.
• W2034352114 cites W2097759417 @default.
• W2034352114 cites W2111424805 @default.
• W2034352114 cites W2112581080 @default.
• W2034352114 cites W2112783820 @default.
• W2034352114 cites W2124805870 @default.
• W2034352114 cites W2148000616 @default.
• W2034352114 cites W2151799181 @default.
• W2034352114 cites W2152088156 @default.
• W2034352114 cites W2168035823 @default.
• W2034352114 cites W4233636966 @default.
• W2034352114 doi "https://doi.org/10.1016/j.surg.2009.10.018" @default.
• W2034352114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20004454" @default.
• W2034352114 hasPublicationYear "2010" @default.
• W2034352114 type Work @default.
• W2034352114 sameAs 2034352114 @default.
• W2034352114 citedByCount "18" @default.
• W2034352114 countsByYear W20343521142013 @default.
• W2034352114 countsByYear W20343521142014 @default.
• W2034352114 countsByYear W20343521142015 @default.
• W2034352114 countsByYear W20343521142016 @default.
• W2034352114 countsByYear W20343521142017 @default.
• W2034352114 countsByYear W20343521142018 @default.
• W2034352114 countsByYear W20343521142019 @default.
• W2034352114 countsByYear W20343521142021 @default.
• W2034352114 countsByYear W20343521142022 @default.
• W2034352114 countsByYear W20343521142023 @default.
• W2034352114 crossrefType "journal-article" @default.
• W2034352114 hasAuthorship W2034352114A5006000018 @default.
• W2034352114 hasAuthorship W2034352114A5009157759 @default.
• W2034352114 hasAuthorship W2034352114A5018778070 @default.
• W2034352114 hasAuthorship W2034352114A5024426707 @default.
• W2034352114 hasAuthorship W2034352114A5027014989 @default.
• W2034352114 hasAuthorship W2034352114A5027538692 @default.
• W2034352114 hasAuthorship W2034352114A5040079063 @default.
• W2034352114 hasConcept C126322002 @default.
• W2034352114 hasConcept C2777397205 @default.
• W2034352114 hasConcept C2779609443 @default.
• W2034352114 hasConcept C2780114680 @default.
• W2034352114 hasConcept C2909467164 @default.
• W2034352114 hasConcept C2911091166 @default.
• W2034352114 hasConcept C3017567848 @default.
• W2034352114 hasConcept C42219234 @default.
• W2034352114 hasConcept C541997718 @default.
• W2034352114 hasConcept C71924100 @default.
• W2034352114 hasConceptScore W2034352114C126322002 @default.
• W2034352114 hasConceptScore W2034352114C2777397205 @default.
• W2034352114 hasConceptScore W2034352114C2779609443 @default.
• W2034352114 hasConceptScore W2034352114C2780114680 @default.
• W2034352114 hasConceptScore W2034352114C2909467164 @default.
• W2034352114 hasConceptScore W2034352114C2911091166 @default.
• W2034352114 hasConceptScore W2034352114C3017567848 @default.
• W2034352114 hasConceptScore W2034352114C42219234 @default.
• W2034352114 hasConceptScore W2034352114C541997718 @default.
• W2034352114 hasConceptScore W2034352114C71924100 @default.
• W2034352114 hasFunder F4320320997 @default.
• W2034352114 hasIssue "3" @default.

• next